552.51 USD
2.06
0.37%
Last update Dec 17, 2:55 PM EST
Main market
Day range
547.16
557.68
Previous close
554.57001
Open
551.02
Access this stock data via API
Subscribe
Madrigal Pharmaceuticals, Inc.
552.51
2.06
0.37%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 180.1M 0 0 0
Cost of revenue 6.2M
Gross profit 173.9M
Operating expense
Research & development 236.7M 272.4M 245.4M 205.2M
Selling general and admin 435.1M 108.1M 48.1M 37.3M
Other operating expenses
Operating income -497.9M -380.5M -293.6M -242.5M
Non operating interest income
Income 46.7M 19.6M 2.2M 363K
Expense 14.7M 12.7M 4.0M 0
Other income expense 273K
Pretax income -465.9M -373.6M -295.4M -241.8M
Tax provision
Net income -465.9M -373.6M -295.4M -241.8M
Basic EPS -21.9 -20.0 -17.2 -14.6
Diluted EPS -21.9 -20.0 -17.2 -14.6
Basic average shares 21.3M 18.7M 17.1M 16.5M
Diluted average shares 21.3M 18.7M 17.1M 16.5M
EBITDA -450.1M -360.4M -290.9M -241.4M
Net income from continuing op. -465.9M -373.6M -295.4M -241.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 1 hour

14:59
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).